Aug. 2 P&P Quick Takes: Pediatric disease voucher guidance clarified, CMS proposes rule on hospital price transparency and draft guidance on clinical trial prac

Update to pediatric disease guidance clarifies what qualifies
FDA updated its draft guidance on rare pediatric disease priority review vouchers to include provisions from the

Read the full 240 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE